Sep 29, 2024, 01:39
Chadi Hage Chehade: Post Hoc analysis of ph3 VISION trial prostate cancer
Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared on X:
“Just out in European Urology.
Check out our editorial highlighting a post hoc analysis of ph3 VISION trial prostate cancer.
In patients receiving Lu-177, extent of PSA response correlated with survival outcomes and PROs.”
Source: Chadi Hage Chehade/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 29, 2024, 04:28
Sep 29, 2024, 03:57
Sep 29, 2024, 03:36
Sep 29, 2024, 01:39
Sep 28, 2024, 20:20
Sep 28, 2024, 20:14